Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest two worth $150 million The company was incubated by AI pharmaceutical unicorn XtaiPl, whose most recent valuation exceeded $2.
Read more: https://www.benzinga.com/news/22/04/26596254/ai-pharma-startup-metis-raises-150-million-ipo-in-sight